Strengths and Weaknesses of TB Drug Management Democratic Republic of Congo, Congo Brazzaville, Uganda, Nigeria, and Benin - PowerPoint PPT Presentation

Slide1 l.jpg
Download
1 / 7

  • 388 Views
  • Updated On :
  • Presentation posted in: Travel / Places

Strengths and Weaknesses of TB Drug Management Democratic Republic of Congo, Congo Brazzaville, Uganda, Nigeria, and Benin. Group 1 Countries. Uganda Democratic Republic of Congo Congo Brazzaville Nigeria Benin Republic. Policy and Legal Framework: Strengths.

Related searches for Strengths and Weaknesses of TB Drug Management Democratic Republic of Congo, Congo Brazzaville, Uganda, Nigeria, and Benin

I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.

Download Presentation

Strengths and Weaknesses of TB Drug Management Democratic Republic of Congo, Congo Brazzaville, Uganda, Nigeria, and Benin

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Slide1 l.jpg

Strengths and Weaknesses of TB Drug Management

Democratic Republic of Congo, Congo Brazzaville, Uganda, Nigeria, and Benin


Slide2 l.jpg

Group 1 Countries

  • Uganda

  • Democratic Republic of Congo

  • Congo Brazzaville

  • Nigeria

  • Benin Republic


Slide3 l.jpg

Policy and Legal Framework: Strengths

  • NDP is present in all countries. In Congo Brazzaville, it is developed but not implemented.

  • Most countries have TB drugs on the EDL (except DRC).

  • Special consideration for donated drugs; all require evidence of quality control (+, -).


Slide4 l.jpg

Policy and Legal Framework: Weaknesses

  • Weak enforcement of policies, also in the private sector

  • Labs for QC not adequate

  • DOTS not widespread (except Benin)

  • Government funding levels inadequate (except Benin)


Slide5 l.jpg

Selection Process

  • All countries have protocols (STGs), however each country’s STGs may differ

    • Weakness: Forms and dosages differ within country

  • Regimen changes have been successful

    • Weakness: Problems with wastage


Slide6 l.jpg

Distribution and Use

  • All NTP involved in quantification

    • Weakness: Data questionable (except Benin, CB)

  • Drug management information systems are sometimes weak

  • Movement of drugs from the central to the regional level works well

    • Weakness: Movement from the regional to peripheral level is a problem


Slide7 l.jpg

Distribution and Use, continued

  • Use of blister packs has improved compliance and reduced wastage (Nigeria, Uganda)


  • Login